INDmoney
BEAM
Beam Therapeutics Inc Earnings
$28.47
Earnings Summary
Revenue | $114.11Mn |
Net Profits | $244.3Mn |
Net Profit Margins | 214.09% |
Beam Therapeutics Inc’s revenue jumped 279.52% since last year same period to $114.11Mn in the Q4 2025. On a quarterly growth basis, Beam Therapeutics Inc has generated 1076.62% jump in its revenue since last 3-months.
Beam Therapeutics Inc’s net profit jumped 370.38% since last year same period to $244.3Mn in the Q4 2025. On a quarterly growth basis, Beam Therapeutics Inc has generated 316.71% jump in its net profits since last 3-months.
Beam Therapeutics Inc’s net profit margin jumped 171.24% since last year same period to 214.09% in the Q4 2025. On a quarterly growth basis, Beam Therapeutics Inc has generated 118.42% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.16 |
EPS Estimate Current Year | -1.16 |
Beam Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.16 - a -14.85% fall from last quarter’s estimates.
Beam Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -1.16.
Key Ratios
Earning Per Share (EPS) | 0 |
Beam Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Beam Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-12 | -1.16 | 0 | 100% |
